Laddar...
Safety and efficacy of apatinib combined with iodine-125 in chemotherapy-refractory advanced lung cancer: A case report
INTRODUCTION: Apatinib is a novel anti-angiogenic agent that targets vascular endothelial growth factor receptor-2, and is effective in patients with advanced lung cancer who are refractory to first-line chemotherapy. However, there are limited reports on concurrent apatinib therapy with iodine-125...
Sparad:
| I publikationen: | Medicine (Baltimore) |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Lippincott Williams & Wilkins
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7437787/ https://ncbi.nlm.nih.gov/pubmed/32872014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000021600 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|